Tech Company Financing Transactions
NextVivo Funding Round
On 12/10/2021, NextVivo raised $7.9 million in funding from Khosla Ventures, Alexandria Venture Investments and Wilson Sonsini Goodrich & Rosati.
Transaction Overview
Company Name
Announced On
12/10/2021
Transaction Type
Venture Equity
Amount
$7,900,000
Round
Undisclosed
Investors
Khosla Ventures (Lead Investor) (Vinod Khosla)
Proceeds Purpose
NextVivo plans to develop the first organoid platform able to generate and test therapies in immune-competent human-derived models.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3160 Porter Dr.
Palo Alto, CA 94304
USA
Palo Alto, CA 94304
USA
Phone
Undisclosed
Website
Email Address
Overview
We are a team of scientists and dreamers who share a set of values to promote an enabling, transparent, team oriented, mission driven culture. We all want to change the world for the benefit of patients. If we succeed, our culture will be our secret sauce.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adam Margolin
Chief Scientific Officer
Cecile Chartier
Co-Founder
Mark Davis
Co-Founder
Calvin Kuo
Browse more venture capital transactions:
Prev: 12/10/2021: K36 Therapeutics venture capital transaction
Next: 12/10/2021: CloudBees venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs